Diluks De Silva

Placeholder Person Graphic
Chiron/Novartis
Diluks De Silva joined Chiron/Novartis site in Vacaville, California, in 2001 and has held roles of increasing responsibilities within the technical operations quality organization. In 2013, Diluks joined the bioproduction operations Singapore quality team to build and commission a new 700 MUSD cell culture production site. Over the past three years, Diluks was responsible for designing and managing the quality organization for cell and gene operations in Morris Plains, New Jersey. Currently, Diluks is responsible for leading the North Americas regional quality organization for Advanced Accelerator Applications, a Novartis company. Diluks holds a BS in biology from California State University, Sacramento.

Related Articles

Navigating the Life Cycle for Cell & Gene Therapies
Features
Navigating the Life Cycle for Cell & Gene Therapies

Cell and gene therapies are complex. As more therapies come to market in the hope of bringing advanced treatments and cures to rare, orphan, and difficult-to-treat diseases, designing quality standards for these personalized medicines is equally as complex.1

  • 1European Commission. EudraLex, Volume 4: EU Guidelines for GMPs for Medicinal Products for Human and Veterinary Use. Part 4:...